擴張型心肌病合并心力衰竭經(jīng)黃芪注射液聯(lián)合磷酸肌酸鈉治療的效果分析

打開文本圖片集

【摘要】目的：探究擴張型心肌病合并心力衰竭患者采用中西聯(lián)合治療方案的臨床效果及其生活狀態(tài)的改善情況。方法：以80例擴張型心肌病合并心力衰竭患者開展研究，隨機均分為對照組（磷酸肌酸鈉治療）和觀察組（磷酸肌酸鈉聯(lián)合黃芪注射液治療），以患者左心室相關指標、生活質(zhì)量指標評估治療方案。結果：治療后，觀察組患者臨床效果較好，左心室相關指標水平明顯優(yōu)于對照組（P

【關鍵詞】擴張型心肌?。恍牧λソ?；黃芪注射液；磷酸肌酸鈉；生活質(zhì)量

Study on the effect and quality of life of astragalus injection combined with creatine phosphate in the treatment of dilated cardiomyopathy complicated with heart failure

CHEN Ru

Qingdao City，People’s Hospital of Chengyang District， Qingdao， Shandong 266000， China

【Abstract】Objective：To investigate the clinical effect of combined Chinese and western therapy regimens and the improvement of their living conditions in patients with dilated cardiomyopathy and heart failure.Methods：A total of 80 patients with dilated cardiomyopathy and heart failure were randomly divided into control group（sodium creatine phosphate treatment）and observation group （sodium creatine phosphate combined with astragalus injection treatment），and the treatment plan was evaluated by the patients’ left ventricle related indicators and quality of life indicators.Results： After treatment，the clinical effect of the patients in the observation group was better，and the levels of left ventricular related indicators were significantly better than those in the control group（P

【Key Words】Dilated cardiomyopathy； Heart failure； Astragalus injection； Sodium creatine phosphate； Quality of life

擴張型心肌病為原發(fā)性心肌疾病，臨床十分常見，癥狀以充血性心力衰竭為主，影響患者生活能力。（剩余4032字）